Saibal Kar
Latest contributions
Updates in tricuspid interventions: from the procedure to follow-up
15 Apr 2025
Register for free to this webinar on 6 May at 5:00pm (UTC+2) with G. Nickenig, J. Dreyfus, S. Kar and P. Lurz and learn about the follow-up results of the TRILUMINATE trial, and so much more!
Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial
02 Apr 2025
Alex Sticchi interviews Saibal Kar about the two-year results of the Triluminate pivotal trial, unveiled at ACC.25 in Chicago.
After revisiting the one-year findings and outlining the study design, Saibal Kar highlights key takeaways: at two years, TriClip therapy significantly reduced heart failure hospitalisations compared to medical...
Author
Author
Management of transcatheter mitral complications: prevention, recognition and bailout
26 Nov 2024 – From PCR London Valves 2024
Curious about managing complications in transcatheter mitral interventions? Don’t miss this video!
You'll get step-by-step guidance on tackling real-world challenges (single leaflet detachment, device embolization...), and learn essential tips and tricks from experienced high-volume operators.
The top clinical cases in interventional cardiology
25 Nov 2024 – From PCR London Valves 2024
Curious about the latest in interventional cardiology? Don't miss this video!
You'll discover groundbreaking techniques for complex conditions, from treating mitral regurgitation after healed endocarditis to repairing the tricuspid valve in dextrocardia. You'll also see the latest advances (including the SAPIEN 3 Tendyne device) and gain expert...
Mind the gap! - What's missing in the field of transcatheter valve interventions
25 Nov 2024 – From PCR London Valves 2024
Explore the key requirements for broadly adopting Transcatheter Mitral Valve Repair (TMVR), examine the challenges of Left Ventricular Outflow Tract Obstruction in Mitral Valve Replacement (MVR), and identify the additional tools needed for effective mitral valve repair. This session will provide a comprehensive assessment of the...
Mitral TEER - Advanced skills (challenging anatomy - when, why and how?)
24 Nov 2024 – From PCR London Valves 2024
Curious about how to tackle complex mitral valve anatomies with transcatheter edge-to-edge repair (TEER)? This video dives straight into advanced techniques for challenging cases, delivering expert insights on expanding indications, optimal patient selection and precise procedural strategies.
Through real-world case presentations, you’ll learn the “when, why, and...
Breaking new ground in mitral valve interventions
24 Nov 2024 – From PCR London Valves 2024
What’s shaping the future of mitral valve therapies? This video from PCR London Valves 2024 unveils groundbreaking late-breaking trials that redefine the possibilities in mitral interventions.
You'll explore real-world insights from the OCEAN-Mitral registry on the MitraClip G4, uncover the link between tricuspid regurgitation and 3-year mortality...
Rapid-fire - Challenging structural interventions
21 Nov 2023 – From PCR London Valves 2023
Discover complex scenarios in structural interventions in this session: encounter an uncommon complication – ventricular septal defect – arising from transcatheter aortic valve replacement, delve into the decision-making process for a ventricular septal defect post-myocardial infarction in a young patient, navigate through the complexities of embolic...
20 years of TEER: a journey at the crossroads of the human heart
20 Nov 2023 – From PCR London Valves 2023
In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Key questions in mitral valve intervention - What do I need to know about imaging?
19 Nov 2023 – From PCR London Valves 2023
Explore the crucial aspects of imaging in mitral valve intervention with a focus on the entire treatment pathway, from patient selection to post-procedural follow-up. Gain insights into optimizing patient selection for mitral valve edge-to-edge repair and replacement, and learn key views essential for optimal imaging and...
HighLife TSMVR and their latest experiences, moving forward
29 Nov 2022 – From PCR London Valves 2022
A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.
Transcatheter mitral valve interventions: clinical outcomes 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...
How are MitraClip experience and proven outcomes influencing real-life clinical practice?
09 Nov 2021
Discover the replay of this PCR Webinar on MitraClip with H. Ince, S. Kar, W. Rottbauer and R. von Bardeleben
#1 - How are MitraClip experience and proven outcomes influencing real-life clinical practice?
19 Oct 2021
Discover the replay of this PCR Webinar on MitraClip with H. Ince, S. Kar, W. Rottbauer and R. von Bardeleben
Tailoring mitral repair: new evidence demonstrating improved patient outcomes
27 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to tailor the mitral valve repair and optimise treatment based on etiology and mitral valve anatomy and to learn about current MitraClip clip options as well as look into the future of the mitral repair treatment.
Primary mitral regurgitation in 2019: how to deliver the best treatment to our patients
05 Dec 2019 – From PCR London Valves 2019
Consult this session on primary mitral regurgitation to learn more about the current practice and advanced surgical and transcatheter techniques, and discover key tips and tricks that will improve procedural outcomes in your everyday clinical practice.
Mitral and tricuspid transcatheter valves therapies: time to innovate!
Consult this session on mitral and tricuspid transcatheter valves therapies to learn all about the recent innovations and clinical evidences, and discover the Tendyne Clinical Program, a new transcatheter treatment option that eliminates mitral regurgitation.
Mitral regurgitation: a comprehensive patient-based approach
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the pathophysiology of mitral regurgitation, and discover its implications for device design, selection and durability, which imaging modality is the most relevant to clinical decision-making, and how Heart Team working can provide the best treatment option for complex patients.
Will the COAPT study change treatment of mitral regurgitation?
More effective, safer treatment is needed for functional mitral regurgitation (FMR), a consequence of myocardial disease and left ventricular disease, which is associated with poor quality of life and high mortality rates. Join Ralph Stephan von Bardeleben, Patrice Guerin and Saibal Kar as they examine the...
EuroPCR 2019 Hot Line and Trial Update
21 May 2019 – From EuroPCR 2019
Consult this session to learn all about the results of the latest trials : discover more about the COAPT trial, examining the relationship between residual mitral regurgitation and clinical outcomes, the GLOBAL Leaders substudy, examining ticagrelor monotherapy in complex PCI, and the BIO-RESORT, determining the clinical outcomes following treatment...
Safety and effectiveness of transcatheter mitral leaflet approximation with MitraClip in heart failure patients with secondary mitral regurgitation
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the safety and effectiveness of transcatheter mitral leaflet approximation with MitraClip in heart failure patients with secondary mitral regurgitation, thanks to the results of the COAPT and MitraClip Japan trials.
